ADVFN - Advanced Financial Network.
HOME» NYSE » B » BSX Stock Price » BSX Stock News

Boston Scientific Share News

 Boston Scientific Corp. Stock Price
BSX Stock Price
 Boston Scientific Corp. Stock Chart
BSX Stock Chart
 Boston Scientific Corp. Stock News
BSX Stock News
 Boston Scientific Corp. Company Information
BSX Company Information
 Boston Scientific Corp. Stock Trades
BSX Stock Trades

Boston Scientific To Acquire Cameron Health To Build On Heart-Rhythm Business

DOW JONES NEWSWIRES Boston Scientific Corp. (BSX) will acquire privately held company Cameron Health Inc., expanding its key heart-rhythm business. Cameron Health developed the only commercially available subcutaeneous implantable defibrillator, which is an alternative to traditional defibrillators. Boston Scientific will pay $150 million upfront and an additional potential $150 million upon the U.S. Food and Drug Administration's approval of Cameron's S-ICD system. The agreement also calls for up to an additional $1.05 billion in revenue-based milestone payments over a six-year period after FDA approval. The deal is expected to close in the second or third quarter this year. "The acquisition of Cameron Health builds on Boston Scientific's commitment to introducing innovation in the (cardiac rhythm management) space and represents an important part of our strategy to generate top-line revenue and market share growth," said Chief Executive Hank Kucheman. Cameron's S-ICD system sits below the skin and doesn't touch the heart and blood vessels, while conventional implantable defibrillators require thin, insulated wires to pass through the venous system and into the heart. The system has been commercially available in several major European countries since 2009. Cameron received expedited review status and submitted its application to the FDA in December. Boston Scientific anticipates FDA approval in the first half of 2013. Last month, Boston Scientific reported fourth-quarter earnings fell 55% on sales declines in its heart-rhythm and drug-eluting stents businesses as the medical-device maker struggles to grow its revenue amid weakness in key markets. Shares closed at $5.93 Thursday and were unchanged after hours. The stock is up 11% so far this year. -By Nathalie Tadena, Dow Jones Newswires; 212-416-3287; nathalie.tadena@dowjones.com

Stock News for Boston Scientific (BSX)
DateTimeHeadline
05/20/201512:15:10What Is the S&P 500 Index?
05/20/201502:31:00Post-Market Study Evaluating The Boston Scientific Lotus⢠Valve S...
05/19/201516:21:25Statement of Changes in Beneficial Ownership (4)
05/19/201516:21:25Statement of Changes in Beneficial Ownership (4)
05/19/201507:52:00New Data Presented At EuroPCR 2015 Demonstrate Strong Performance...
05/15/201508:30:28Statement of Changes in Beneficial Ownership (4)
05/12/201515:08:32Current Report Filing (8-k)
05/12/201510:53:00Boston Scientific Completes $1.85 Billion Senior Notes Offering
05/11/201516:06:47Statement of Changes in Beneficial Ownership (4)
05/11/201509:24:00Boston Scientific Announces Scheduled Presentations at Heart...
05/08/201517:03:06Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)
05/08/201506:04:05Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
05/08/201506:04:04Current Report Filing (8-k)
05/07/201517:38:00Boston Scientific Prices $1.85 Billion Of Senior Notes
05/07/201516:28:32Statement of Changes in Beneficial Ownership (4)
05/07/201516:28:32Statement of Changes in Beneficial Ownership (4)
05/07/201516:28:32Statement of Changes in Beneficial Ownership (4)
05/07/201516:28:32Statement of Changes in Beneficial Ownership (4)
05/07/201516:28:32Statement of Changes in Beneficial Ownership (4)
05/07/201516:28:32Statement of Changes in Beneficial Ownership (4)

Boston Scientific and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad